Limited preclinical and clinical data suggest that GLP-1 receptor agonists might modestly influence cortisol metabolism or HPA axis function in certain contexts, but findings have been inconsistent and not practice-changing
Legal and regulatory risks Not approved as a drug, supplement, or food in the US, EU, Australia, and other major markets
Monitoring and Restarting Treatment If Needed Regular weigh-ins at intervals set by your prescriber, commonly about every 4 weeks after stopping medication help you detect regain early, when smaller interventions may prevent large-scale loss
Safety Note: If you ever experience a firm lump in the front of your neck, difficulty swallowing that doesn't go away, or a persistent hoarse voice, you must see your GP for an urgent physical examination, regardless of whether you are taking GLP-1 medications or what your blood test results show